Our mission

To develop evidence-based digital health technologies which promote self-management and improve outcomes of mental health problems.

About Affigo.io

We are a Manchester-based social enterprise company established in December 2015. A team of clinicians, academics and software engineers, we work closely with mental health service users to develop innovative digital technologies which we test in the health service to ensure they are safe, acceptable and effective. We aspire to provide the self-management system of choice across the UK initially, but also internationally.


Our products have been developed in partnership with service users, caregivers, clinicians and the public. Our apps have evolved to offer the greatest benefits and fewest disruptions to the lives of people they are designed to support. Throughout development and even today, we are working with a service user advisory group, meeting every three months, to get a range of opinions as to how our technology can best serve service users and the community.

  • Our products have been developed in conjunction with service users and with the NHS by internationally renowned clinical academics, clinicians and expert software engineers
  • Funded by the highest quality Medical Research Council funding
  • Rigorous testing with randomised controlled trials
  • Successful integration of our technology system within NHS Trust ICT systems
  • Proven safety, feasibility, acceptability, validity and efficacy

Our social mission

To empower people to monitor and manage their own health

We set up a Social Enterprise Company because we believe this approach will deliver the biggest gain for helping with mental health problems. Rather than limit our products for use within an academic setting, we want to improve our ability to make our products available beyond the research context. That’s why we set up a social enterprise company, to ensure that we can support further research and develop new products that enhance the ClinTouch technology so that it can help people with long-term and enduring health problems.

Current products


ClinTouch is both a platform technology and a stand-alone app that helps people with psychosis start to manage their own symptoms. It is based around a Smartphone app developed by a team of service users, leading clinicians and academics, software engineers and health professionals at The University of Manchester and Manchester NHS Trusts. ClinTouch is built around a Smartphone application which triggers, collects and wirelessly uploads symptom data in real-time to a central server at the clinical team base. The provision of diary entries encourages service users to record information relevant to how they are feeling, allowing for greater contextualization of data, leading to more informed discussions between service user and healthcare professional. Graphical information highlighting general mood and behavior patterns allows the service users and clinicians to track their progress and understand their experiences more clearly.

ClinTouch Integrated – As well as a stand-alone app, ClinTouch Integrated offers complete mobile support technology for people with psychosis and their clinical team. ClinTouch Integrated can be fully or partially integrated with your NHS Trust or service provider ICT systems depending on your needs.

ClinTouch is adaptable to all mental and physical long-term conditions that have fluctuating symptoms. For instance, it is currently trialled in people with rheumatoid arthritis.

ClinTouch - How it works

ClinTouch is both a stand alone app and end-to-end clinical management system (ClinTouch Integrated) aimed at predicting and averting relapse in psychosis.

ClinTouch works as a personalised Smartphone app that triggers the collection of real-time symptom data from a mobile handset touchscreen that wirelessly uploads data to a secure central server several times daily.

Starting in 2013, we have built ClinTouch into an end-to-end system in community mental health teams in Manchester and South London so that summary data and personalised early warning alerts for relapse are available for healthcare staff. Summary data are viewed by healthcare professionals and a are streamed into e-care records.


Features & specifications

  • Validated questionnaire for monitoring symptoms, which means clinicians can be confident of high quality data
  • Prompts for patients to answer questionnaire items several times daily, which means that a highly detailed readout of symptom change is possible
  • Questions can be personalised to match an individual, which means more accurate and relevant data
  • Question branching to reduce time taken to complete questions, which means it takes around 70 seconds to complete
  • Wireless upload of data in real time, which reduced error in recalling symptoms and experiences
  • Responses stored and wirelessly uploaded to a secure server, ensuring high levels of safety and privacy
  • Daily diary function encourages people to self-manage
  • Graphs of symptom changes over time, which enables sharing of summary data with friends, family, GPs and other healthcare professionals
  • Web-based interface for clinicians that provides real-time access to questionnaire responses
  • Algorithms to alert clinicians when a patient symptoms have reached a personalised threshold indicating imminent relapse, which gives the potential for early detection and intervention
  • Export of validated results for integration with other tools and further analysis and research, which means ClinTouch is a platform for research as well as clinical management
  • Third party API integration with e-health records, which means summary clinical data can be streamed into NHS electronic care records

Research Evidence - ClinTouch

2009: Team develop first prototype for ClinTouch in sms and Android smartphone formats.

2010: First Medical Research Council (MRC) grant funds expansion of the programme with further functionality, beta testing, field trials and first randomised trials. We use “experience-driven design”, including people with SMI in all aspects of development.

2012: Second successful MRC grant enabled software systems to be further developed. Fully functional end-to-end solution for remote monitoring embedded in a care service built and tested. The system provides real time information to care coordinators and clinical teams on a client’s progress. In addition, it gives real time alerts if a client shows personalised early warning signs for relapse, allowing for very early intervention to avert this.

2014: In-depth randomised, controlled trial was conducted with 80 service users registered across two NHS clinical care teams in Manchester and South London to examine the benefit of the ClinTouch-Integrated management system over routine care. This detailed roll out and evaluation of the system provided evidence of: i) safety, feasibility, acceptability and validity of the system when embedded in routine clinical practice; ii) clinical benefit for mental health symptoms particularly for those at the early stage of psychosis; iii) functional ability to pick up an individual’s early warning signs.

Highlighted findings

  • ClinTouch is safe to use and is the only SMI system to have robust safety data: only 5% of users with psychosis reported increased anxiety or paranoia.
  • Confirmed in 2011, ClinTouch measures positive and mood symptoms accurately as benchmarked by gold standard rating scales.
  • ClinTouch is acceptable to 40-50% of a representative sample of people with psychosis, 90% of whom continued to use it consistently for at least 3 months.
  • ClinTouch is acceptable to healthcare professionals: in our largest, trial, 100% of professionals accessed the ClinTouch system on the team desktop an overage of 24 times over 12 weeks.
  • Compared to standard care, ClinTouch leads to significantly faster improvement in psychotic symptoms in early psychosis.
  • Findings from our extensive qualitative work show that people feel a greater sense of empowerment and self-awareness of their symptoms and experiences over time, resulting in improved self-management.


  • This is a game changer. If initiated across the national health, it would massively change the picture of mental health...the way clinicians work, the outcomes for clients, everything

    Commercial and market appraisal by Prism Ideas Ltd
  • It will transform our ability to provide good quality care

    Prism Ideas Ltd


Our training package provides the latest training for recognition of early warning signs of psychosis, implementation of the ClinTouch system into routine service delivery and technical support.

  • Book a one day face-to-face clinical and technical support training workshop with members of the Affigo.io team
  • Download online training materials
  • Download our training guide

Our Team

Affigo.io is a social enterprise company (Community Interest Company) limited by guarantee. The Directors have been involved in various stages from inception, through growth and development of our products. Our team is comprised of national and international leading clinicians, academics and expert software engineers, based at The University of Manchester, UK.

Professor Shôn Lewis

Professor Shôn Lewis

    Professor Shôn Lewis is Professor of Adult Psychiatry at The University of Manchester, UK and a consultant psychiatrist with Manchester Mental Health and Social Care Trust. He is an internationally leading researcher and clinician in severe mental health problems, with over 200 published academic papers. Professor Lewis represents Affigo.io in face-to-face meetings with potential customers. He is the head of Affigo.io research and funding opportunities.

    Professor John Ainsworth

    Professor John Ainsworth

      John Ainsworth is Professor of Informatics at the University of Manchester. He has wide experience in the Industry sector as well as in academia. He is Deputy Director of the MRC-funded Health e-Research Centre (HERC). Prof Ainsworth is Affigo’s head of software engineering operations and oversees management of the company.

      Professor Sandra Bucci

      Professor Sandra Bucci

        Sandra Bucci is Professor of Clinical Psychology at The University of Manchester. She is an honorary Consultant Clinical Psychologist at Greater Manchester Mental Health NHS Foundation Trust. Prof Bucci is an internationally-leading researcher in psychological interventions for psychosis and has worked around the world as a practicing Clinical Psychologist and clinical academic, with nearly 20 years experience in mental health.

        Charlotte Stockton-Powdrell

        Charlotte Stockton-Powdrell

          Charlotte Stockton-Powdrell has wide experience of health research governance and regulatory issues and managing clinical trials. She is a qualified PRINCE 2 Project Manager and Affigo.io company secretary. Charlotte is responsible for administrative tasks and the day to day running of Affigo.io and is the central point of contact for potential customers.

          Contact us


          Email: charlie@affigo.io